Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
How to Earn $10,000 a Year in Passive Retirement Income
11:00am, Sunday, 10'th Jul 2022
You'll either need a decent chunk of change or some patience.
3 Unstoppable Dividend Stocks to Buy and Never Sell
05:58am, Sunday, 10'th Jul 2022
All three of these companies have strong underlying businesses and offer attractive dividends.
2 Surefire Dividend Stocks I'd Buy Now and Hold for at Least a Decade
05:21am, Sunday, 10'th Jul 2022
These dividend-paying stocks have reliable cash flows, but they've been beaten down to some very attractive prices.
AbbVie Stock: Bull vs. Bear
07:00am, Saturday, 09'th Jul 2022
The stock is beating the bear market.
AbbVie to Host Second-Quarter 2022 Earnings Conference Call
08:00am, Friday, 08'th Jul 2022
NORTH CHICAGO, Ill. , July 8, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2022 financial results on Friday, July 29, 2022, before the market opens.
Want to Beat the Bear Market? Try These 2 Stocks
06:00am, Friday, 08'th Jul 2022
There's plenty of growth ahead for these companies.
What's Driving AbbVie Stock Higher?
05:00am, Friday, 08'th Jul 2022
AbbVie stock (NYSE: ABBV) has seen a 14% rise YTD, marking a significant outperformance compared to some of its peers and the broader markets, with Johnson & Johnson stock rising 4%, Pfizer stock down
AbbVie: Investors Don't Have Too Much To Fear Ahead Of Q2 Earnings
04:44pm, Thursday, 07'th Jul 2022
AbbVie shares have been on a long bull run but experienced a slight wobble after Q1'22 earnings were announced. That is to do with the imminent patent expiry of its $20bn per annum selling drug Humira
The direction of M&A in biotech is very, very vast, says Oppenheimer's Holz
03:24pm, Thursday, 07'th Jul 2022
Jared Holz, Oppenheimer healthcare equity strategist, joins 'Power Lunch' to discuss the possibility of M&A in the healthcare sector, if investors remain focused on the oncology side of healthcare bus
Senate Finance report says AbbVie shifted profit overseas to cut taxes
02:02pm, Thursday, 07'th Jul 2022
Drugmaker AbbVie Inc generates most of its sales in the United States, while shifting most of its profits overseas in order to avoid U.S. taxes, an interim report from the Senate Finance Committee sai
Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King
06:39am, Thursday, 07'th Jul 2022
ABBV stock is one of the best choices you can make for 2022. Even though the company is losing its Humira patent soon, it isn't slowing down.
We Are in a Recession: 7 Dividend Aristocrats Are the Best Second-Half Ideas
09:23am, Tuesday, 05'th Jul 2022
The second-quarter gross domestic product (GDP) is likely to end up being negative, as the latest data from the Atlanta Fed's GDPNow tracker predicts real GDP growth of −1.0% as of June 30, down fro
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
07:30am, Tuesday, 05'th Jul 2022
Rinvoq could be approved to treat patients in the European Union with ulcerative colitis.
7 Dividend Stocks to Buy in July 2022
08:56am, Monday, 04'th Jul 2022
Dividend stocks are only becoming more attractive as income becomes increasingly paramount. These seven equities pair dividends with safety.
3 Stocks You Can Buy and Hold for Decades
05:57am, Saturday, 02'nd Jul 2022
These companies are built to last.
